ProfileGDS5822 / ILMN_1230724
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 53% 41% 60% 30% 1% 52% 57% 62% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 123.153
GSM1276600PDAC Late Ablation Control 220.541
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 126.260
GSM1276603PDAC Late Ablation 21530
GSM1276604PDAC Late Ablation 32.61
GSM1303940PDAC Late Ablation_anti-CTLA4 122.952
GSM1303941PDAC Late Ablation_anti-CTLA4 231.857
GSM1303942PDAC Late Ablation_anti-CTLA4 341.962